How does Zepbound (tirzepatide) work for weight loss?
Zepbound® is an injectable medication that is a combination GIP/GLP-1 receptor agonist. It is approved for weight loss in adults with a body mass index (BMI) of 30+ kg/m2 or 27+ kg/m2 with weight related medical problems such as high blood pressure, diabetes and high cholesterol in combination with a low calorie diet and increased physical activity. It mimics two hormones our body naturally makes: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). GLP-1 acts on the pancreas to stimulate the release of insulin which lowers blood sugar and acts on the brain to decrease appetite and cravings. The addition of a GIP agonist to a GLP-1 agonist has been found to promote additional weight loss. In clinical trials, individuals who took tirzepatide for up to a year and a half, lost an average of 26.6% of their body weight.
Learn more about how Form Health prescribes Zepbound to help patients reach their weight loss goals.
Zepbound® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.